[Webinar] Next Gen Drug Screening: State of the Market and Where It’s Going

April 4th, 11:00 am CST
Mitratech Holdings, Inc
April 4th, 2024
11:00 AM CST

Explore the future of drug screening.

$81 billion...

That's how much the National Council on Alcoholism and Drug Dependence (NCADD) estimates drug abuse costs employers every year.

Avoid paying the price and dive into the cutting-edge of drug screening with our speakers Mitratech’s Sarah Carr and Premier BioTech’s Casey Michalik and Jenna Stainbrook on April 4th at 11:00 AM CST for an informative webinar exploring recent shifts in drug screening, the move toward oral tox screening, and how organizations can be successful while embracing change.

Key Insights You'll Gain:

  • State of the Market: Understand the recent shifts shaping the future of drug screening as we look into the latest market dynamics

  • Shifting to Oral Tox: Uncover the “why” behind the industry's significant shift to oral tox screening. Learn how this shift is revolutionizing the way we approach drug screening.

  • Success Stories Showcase: Hear real-world success stories from those who have embraced the next generation of drug screening. Gain valuable insights into the impact on efficiency, accuracy, and overall outcomes.

  • Q&A Session: Have your questions answered and gain additional insights into the evolving landscape of drug screening.

Stay ahead of the curve and position your organization for success in the evolving world of drug screening. Reserve your spot now for this insightful and forward-thinking webinar.


Mitratech Holdings, Inc

Mitratech Holdings, Inc on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide